Publikationen, an denen er mitarbeitet Pedro Pablo Medina Vico (10)

2023

  1. BCL7A is silenced by hypermethylation to promote acute myeloid leukemia

    Biomarker Research, Vol. 11, Núm. 1

2022

  1. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

  2. Opportunities of miRNAs in cancer therapeutics

    MicroRNA in Human Malignancies (Elsevier), pp. 153-164

  3. PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer

    Cellular Oncology, Vol. 45, Núm. 2, pp. 323-332

2020

  1. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  2. Correction: Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer (Oncogene, (2020), 39, 32, (5479-5493), 10.1038/s41388-019-1129-3)

    Oncogene

  3. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Leukemia, Vol. 34, Núm. 10, pp. 2722-2735

  4. LncRNA DLG2-AS1 as a novel biomarker in lung adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-10

  5. Lncrna-mrna co-expression analysis identifies al133346.1/ccn2 as biomarkers in pediatric b-cell acute lymphoblastic leukemia

    Cancers, Vol. 12, Núm. 12, pp. 1-15

  6. Plakophilin 1 enhances MYC translation, promoting squamous cell lung cancer

    Oncogene, Vol. 39, Núm. 32, pp. 5479-5493